Raj Shrivastava, MD
- PROFESSOR | Neurosurgery
- PROFESSOR | Otolaryngology
Research Topics:Anatomy, Anti-Tumor Therapy, Bioinformatics, Brain, Brain Imaging, Clinical Genomics, Computer Simulation, Genomics, MRI, Neural Networks, Neuroscience, Pituitary, Robotic Surgery, Systems Neuroscience, Translational Research
Dr. Raj Shrivastava is a board-certified Professor of Neurosurgery and Otolaryngology (ENT) and Vice Chair for Clinical Affairs for the Department of Neurosurgery at the Mount Sinai Health System. He specializes in the diagnosis and treatment of skull base tumors, meningiomas, and pituitary tumors. He has sub-specialty fellowship training in complex skull base surgery that entails the use of minimally invasive technologies consisting of endoscopic, 3D, and stereotactic navigation in order to safely remove difficult and "hard-to-reach" brain tumors. He has been active in the advancement and development of these technologies through clinical research, resulting in several national peer-reviewed publications and awards. Dr. Shrivastava lectures nationally and internationally, often being invited to speak as a guest professor and lecturer.
He is a co-investigator of an NIH-funded study that researches the use of Ultra-High Field 7T MRI mapping of skull base tumors to improve patient outcome and safety. He has been appointed to the editorial board of neurosurgery journals in the sub-specialty area of skull base and endoscopic surgery.
Most importantly, however, Dr. Shrivastava believes that patient-centered care, good clinical outcome and personalized treatment comes first, and this will always be his first priority.
Dr. Shrivastava also serves as Associate Director of the Neurosurgery Residency Program.
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Brain Tumor And Brain Cancer
- Brain Tumors
- Brain, Spine Tumors
- Cerebrospinal Fluid Leak
- Chiari Malformation
- Head and Neck Squamous cell cancer
- Hemifacial Spasm
- Pituitary Adenoma
- Pituitary Diseases
- Pituitary Tumor
- Sinus Cancer
- Skull Base Tumor/Cancer
- Spinal Cord Tumors
- Stereotactic Radiosurgery
- Trigeminal Neuralgia
BS, MS, Stanford University
MD, University of Pennsylvania
Internship, General Surgery, Mount Sinai Hospital
Residency, Neurosurgery, Mount Sinai Hospital
Fellowship, Skull Base Surgery, St. Luke's-Roosevelt Hospital Center
2017, 2019, 2020
New York Magazine Best Doctors
America's Top Surgeon Award
Castle Connolly Top Doctors
US News and World Report Selected Top Doctor-Neurosurgery
Patient's Choice Award - National Award
Compassionate Physician Award - National Award
American Association of Neurosurgeons (AANS) Vesalius Award - First Presentation
Ultra-High Field MRI Tumor Mapping
The BioMedical Engineering and Imaging Institute (BMEII) research group has an NIH funded program that develops newer techniques to accurately map tumors and anatomy using ultra-high field 7T MRI. This will allow for more precise and targeted surgical resections-ultimately for better patient outcomes.
href="https://icahn.mssm.edu/research/bmeii">The BioMedical Engineering and Imaging Institute
Endoscopic Skull Base Surgery
The Endoscopic Skull Base Surgery research group focuses on the clinical implementation of stereotactic and 3D navigation for minimally invasive skull base and pituitary tumor surgery. The team researches unique visual-evoked-potential (VEP) neuro-physiological monitoring to monitor visual pathways during neurosurgical tumor surgery to provide for improved clinical outcome.